TLUNG registry: data analysis of patients with non-squamous NSCLC (adenocarcinoma, large cell carcinoma) and PS 0-1 treated with erlotinib in second line setting.
Authors | |
---|---|
Year of publication | 2013 |
Type | Conference abstract |
Citation |
Authors | |
---|---|
Year of publication | 2013 |
Type | Conference abstract |
Citation |